Table of Contents
What changed
KFL swung from a FY23 loss to a FY24 profit on the back of positive investment returns. Total income (the "revenue" line for this listed investment vehicle) moved from –$14.7m to $26.8m, PBT from –$19.4m to $19.9m, and NPAT from –$19.5m to $19.9m. Despite the P&L turnaround, total equity edged down 0.9% to $457.6m and cash fell from $6.4m to $4.9m. Operating cash inflow was essentially flat at $22.4m versus $22.7m. The declared final dividend stepped down to 2.65c from 2.82c (–6.0%).
What matters
- The result is driven by fair-value movements, not operating activity. The auditor's key audit matter is "Valuation and existence of investments at fair value through profit or loss," and the income line swinging $41.4m between FY23 and FY24 reflects portfolio revaluation rather than recurring cash earnings. This is the central read on quality.
- Second-half recovery did the heavy lifting. HY24 posted a –$14.7m NPAT and –$12.3m income; the full-year outcome therefore implies H2 NPAT of roughly $34.6m and H2 income of $39.1m. The profit is concentrated in the back half and is a direct function of market direction in that window.
- NAV proxy still contracted. Despite reporting a $19.9m NPAT, total equity fell $4.0m, indicating distributions (and any buybacks) exceeded the accounting profit over the year — a directionally weaker signal than the headline earnings growth suggests.
Expectations
No targets, forward work, or outlook commentary were disclosed in the extracted release, so there is no management benchmark to test against. The relevant shape context is the HY24 print, and FY24 clearly depends on an H2 rally rather than a run-rate. Annualising a second-half that delivered ~$34.6m of NPAT would be inappropriate for a fair-value-driven vehicle; the release does not support any view on sustainability beyond "H2 markets were favourable." ROE moved from –4.2% to +4.3%, but that too is a function of portfolio marks.
Quality of result
Earnings quality is low in the traditional sense because the P&L is dominated by non-cash fair-value gains on the investment portfolio. The PBT-to-NPAT gap is negligible (effective tax ~0.1%), so there is no tax distortion — PBT growth of 202.5% and NPAT growth of 202.2% are consistent. More notable is the divergence between accounting profit and cash: operating cash flow actually fell slightly to $22.4m even as reported profit swung by ~$39m, confirming that the earnings uplift is mark-to-market rather than cash-generative. Cash conversion on a like-for-like basis has deteriorated. The final dividend of 2.65c represents a 44.5% payout of NPAT but, against the flat $22.4m of operating cash, is effectively funded by portfolio cash income, not by this year's reported profit swing.
Unresolved
- What was the portfolio composition and attribution behind the H2 turnaround, and how much is concentrated in a small number of holdings?
- Why did total equity decline despite a $19.9m NPAT — what were the full distributions, buyback activity, and other equity movements over the year?
- Full-period dividend picture: the 2.65c disclosed is the final component; total FY24 DPS including any interim is not stated in the extracted data.
- What is NTA per share at balance date, and how does the market price compare (discount/premium)?
- Capex, free cash flow, gross borrowings, and segment/concentration data were not in the extraction, limiting independent cross-checks.
This briefing cannot assess portfolio-level performance attribution, NAV/share price discount dynamics, or management fee and expense drag, since none were disclosed in the extracted material.
Key metrics
| Metric | FY24 | FY23 | Change |
|---|---|---|---|
| Revenue | $26.8m | −$14.7m | +282.4% ↑ |
| Net profit after tax | $19.9m | −$19.5m | +202.2% ↑ |
| Net cash inflow from operating activities | $22.4m | $22.7m | -1.7% ↓ |
| Final dividend per share | 2.6c | 2.8c | -6.0% ↓ |
| Profit before tax | $19.9m | −$19.4m | +202.5% ↑ |
| Cash and cash equivalents | $4.9m | $6.4m | -23.6% ↓ |
| Total assets | $458.9m | $462.2m | -0.7% ↓ |
Reference: annolyse.ai/briefings/kfl-fy24
Analytical metrics
| Metric | FY24 | FY23 | Context |
|---|---|---|---|
| Effective tax rate | 0.1% | n/m (loss period) | prior loss period |
| Payout ratio vs NPAT | 44.5% | — | — |
| ROE (annualised) | 4.3% | -4.2% | Strengthening |
| HY24 share of FY24 revenue | -45.9% | — | Other half was 145.9% |
| HY24 share of FY24 NPAT | -73.8% | — | Other half was 173.8% |
Reference: annolyse.ai/briefings/kfl-fy24
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.